Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins

BackgroundCC chemokine receptor proteins (CCR1 through CCR10) are seven-transmembrane G-protein coupled receptors whose signaling pathways are known for their important roles coordinating immune system responses through targeted trafficking of white blood cells. In addition, some of these receptors have been identified as fusion proteins for viral pathogens: for example, HIV-1 strains utilize CCR5, CCR2 and CCR3 proteins to obtain cellular entry in humans. The extracellular domains of these receptor proteins are involved in ligand-binding specificity as well as pathogen recognition interactions.In mammals, the majority of chemokine receptor genes are clustered together; in humans, seven of the ten genes are clustered in the 3p21-24 chromosome region. Gene conversion events, or exchange of DNA sequence between genes, have been reported in chemokine receptor paralogs in various mammalian lineages, especially between the cytogenetically closely located pairs CCR2/5 and CCR1/3. Datasets of mammalian orthologs for each gene were analyzed separately to minimize the potential confounding impact of analyzing highly similar sequences resulting from gene conversion events.Molecular evolution approaches and the software package Phylogenetic Analyses by Maximum Likelihood (PAML) were utilized to investigate the signature of selection that has acted on the mammalian CC chemokine receptor (CCR) gene family. The results of neutral vs. adaptive evolution (positive selection) hypothesis testing using Site Models are reported. In general, positive selection is defined by a ratio of nonsynonymous/synonymous nucleotide changes (dN/dS, or ω) >1.ResultsOf the ten mammalian CC motif chemokine receptor sequence datasets analyzed, only CCR2 and CCR3 contain amino acid codon sites that exhibit evidence of positive selection using site based hypothesis testing in PAML. Nineteen of the twenty codon sites putatively indentified as likely to be under positive selection code for amino acid residues located in extracellular domains of the receptor protein products.ConclusionsThese results suggest that amino acid residues present in intracellular and membrane-bound domains are more selectively constrained for functional signal transduction and homo- or heterodimerization, whereas amino acid residues in extracellular domains of these receptor proteins evolve more quickly, perhaps due to heightened selective pressure resulting from ligand-binding and pathogen interactions of extracellular domains.

[1]  O. Quehenberger,et al.  Role of the First Extracellular Loop in the Functional Activation of CCR2 , 1999, The Journal of Biological Chemistry.

[2]  C. Kuiken,et al.  Structure and Function of CC-Chemokine Receptor 5 Homologues Derived from Representative Primate Species and Subspecies of the Taxonomic Suborders Prosimii and Anthropoidea , 2003, Journal of Virology.

[3]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[4]  S. Kleeberger,et al.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. , 2006, Cytokine.

[5]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[6]  Fabien Campagne,et al.  Building protein diagrams on the web with the residue-based diagram editor RbDe , 2003, Nucleic Acids Res..

[7]  Z. Navrátilová Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. , 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[8]  T. Williams,et al.  The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down‐regulation in a ligand‐dependent manner , 2005, European journal of immunology.

[9]  N. Ferrand,et al.  Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species , 2006, Immunogenetics.

[10]  D. Shields,et al.  Gene conversion among chemokine receptors. , 2000, Gene.

[11]  D. McDermott,et al.  CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.

[12]  Marc Parmentier,et al.  The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* , 2003, The Journal of Biological Chemistry.

[13]  Zhirong Sun,et al.  Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies , 2003, Journal of molecular modeling.

[14]  Saskia Nijmeijer,et al.  Viral hijacking of human receptors through heterodimerization. , 2008, Biochemical and biophysical research communications.

[15]  Peter H Seeberger,et al.  Profiling heparin-chemokine interactions using synthetic tools. , 2007, ACS chemical biology.

[16]  Alexander O Tarakanov,et al.  Why chemokines are cytokines while their receptors are not cytokine ones? , 2008, Current medicinal chemistry.

[17]  A. Zharkikh,et al.  Concerted evolution of vertebrate CCR2 and CCR5 genes and the origin of a recombinant equine CCR5/2 gene. , 2008, The Journal of heredity.

[18]  M. Hughes,et al.  Prevalence of Chemokine and Chemokine Receptor Polymorphisms in Seroprevalent Children With Symptomatic HIV-1 Infection in the United States , 2004, Journal of acquired immune deficiency syndromes.

[19]  Joseph P. Bielawski,et al.  Maximum likelihood methods for detecting adaptive evolution after gene duplication , 2004, Journal of Structural and Functional Genomics.

[20]  C. Broder,et al.  Chemokine receptors and HIV , 1997, Journal of leukocyte biology.

[21]  A. J. Valente,et al.  Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA , 2000, The Journal of Biological Chemistry.

[22]  S. O’Brien,et al.  Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization. , 2007, Genomics.

[23]  J. Abrantes,et al.  Extensive gene conversion between CCR2 and CCR5 in domestic cat (Felis catus) , 2007, International journal of immunogenetics.

[24]  T. Williams,et al.  Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines. , 2006, Molecular immunology.

[25]  D. S. Garrett,et al.  High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.

[26]  Stephen J O'Brien,et al.  The adequacy of morphology for reconstructing the early history of placental mammals. , 2007, Systematic biology.

[27]  K. Yuen,et al.  Functional Analysis of Naturally Occurring Mutations in the Open Reading Frame of CCR5 in HIV-Infected Chinese Patients and Healthy Controls , 2005, Journal of acquired immune deficiency syndromes.

[28]  Zih E N G Ya N,et al.  On the Best Evolutionary Rate for Phylogenetic Analysis , 1998 .

[29]  A. Mantovani,et al.  Chemokines and chemokine receptors: an overview. , 2009, Frontiers in bioscience.

[30]  Matthew W. Hahn,et al.  Gene Conversion Among Paralogs Results in Moderate False Detection of Positive Selection Using Likelihood Methods , 2009, Journal of Molecular Evolution.

[31]  C. Jean,et al.  Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. , 2008, The Journal of infectious diseases.

[32]  K. Rajarathnam,et al.  Structural Basis of Chemokine Receptor Function—A Model for Binding Affinity and Ligand Selectivity , 2006, Bioscience reports.

[33]  M. Carrington,et al.  Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. , 1999, Human molecular genetics.

[34]  D. McDermott,et al.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. , 2006, Trends in immunology.

[35]  Ziheng Yang PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.

[36]  J. Galzi,et al.  Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor. , 2002, Molecular pharmacology.

[37]  Michael P. Cummings,et al.  PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .

[38]  C. Martínez-A,et al.  The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. , 1997, The Journal of clinical investigation.

[39]  T. Ross,et al.  Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity. , 2004, Virology.

[40]  Ziheng Yang,et al.  PAML: a program package for phylogenetic analysis by maximum likelihood , 1997, Comput. Appl. Biosci..

[41]  David Posada,et al.  MODELTEST: testing the model of DNA substitution , 1998, Bioinform..

[42]  Claudio Napoli,et al.  Understanding the immunoangiostatic CXC chemokine network. , 2008, Cardiovascular research.

[43]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[44]  P. Murphy,et al.  The N-terminal Extracellular Segments of the Chemokine Receptors CCR1 and CCR3 Are Determinants for MIP-1α and Eotaxin Binding, Respectively, but a Second Domain Is Essential for Efficient Receptor Activation* , 1998, The Journal of Biological Chemistry.

[45]  Z. Yang,et al.  Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. , 2001, Molecular biology and evolution.

[46]  Joel Dudley,et al.  TimeTree: a public knowledge-base of divergence times among organisms , 2006, Bioinform..

[47]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[48]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[49]  R. Kaslow,et al.  Cytokine and Chemokine Gene Polymorphisms Among Ethnically Diverse North Americans With HIV-1 Infection , 2004, Journal of acquired immune deficiency syndromes.

[50]  A. Maynard,et al.  Naturally Occurring CCR5 Extracellular and Transmembrane Domain Variants Affect HIV-1 Co-receptor and Ligand Binding Function* , 1999, The Journal of Biological Chemistry.

[51]  W. Wong,et al.  Bayes empirical bayes inference of amino acid sites under positive selection. , 2005, Molecular biology and evolution.

[52]  N. Wig,et al.  Distribution of CCR2 polymorphism in HIV‐1‐infected and healthy subjects in North India , 2007, International journal of immunogenetics.

[53]  P. Hedrick Balancing selection , 2007, Current Biology.

[54]  C. Matthee,et al.  A shared unusual genetic change at the chemokine receptor type 5 between Oryctolagus, Bunolagus and Pentalagus , 2011, Conservation Genetics.

[55]  C. Broder,et al.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.

[56]  D. Graves,et al.  Chemokines, a family of chemotactic cytokines. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[57]  D. Swofford PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .

[58]  M. Rosenkilde,et al.  The chemokine system – a major regulator of angiogenesis in health and disease , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[59]  Elias Lolis,et al.  Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.

[60]  P. Murphy Molecular piracy of chemokine receptors by herpesviruses. , 1994, Infectious agents and disease.

[61]  R. K. Sachdeva,et al.  Gene Polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in Exposed but Uninfected Partners of HIV-1 Infected Individuals in North India , 2006, Journal of Clinical Immunology.